dc.contributor.author | Gichangi, P. | |
dc.contributor.author | Vuyst, H. De | |
dc.contributor.author | Estambale, Benson B. | |
dc.contributor.author | Rogo, K. | |
dc.contributor.author | Bwayo, J. | |
dc.contributor.author | Temmerman, M. | |
dc.date.accessioned | 2018-06-25T13:07:29Z | |
dc.date.available | 2018-06-25T13:07:29Z | |
dc.date.issued | 2002-01-22 | |
dc.identifier.uri | https://obgyn.onlinelibrary.wiley.com/doi/full/10.1016/S0020-7292%2801%2900560-4# | |
dc.identifier.uri | https://doi.org/10.1016/S0020-7292(01)00560-4 | |
dc.identifier.uri | http://ir.jooust.ac.ke:8080/xmlui/handle/123456789/1326 | |
dc.description | https://doi.org/10.1016/S0020-7292(01)00560-4 | en_US |
dc.description.abstract | To determine the effect of the HIV epidemic on invasive cervical cancer in Kenya. Methods: Of the 3902 women who were diagnosed with reproductive tract malignancies at Kenyatta National Hospital (KNH) from 1989 to 1998, 85% had invasive cervical cancer. Age at presentation and severity of cervical cancer were studied for a 9‐year period when national HIV prevalence went from 5% to 5–10%, to 10–15%. Results:There was no significant change in either age at presentation or severity of cervical cancer. Of the 118 (5%) women who were tested for HIV, 36 (31%) were seropositive. These women were 5 years younger at presentation than HIV‐negative women. Conclusions: A two‐ to three‐fold increase in HIV prevalence in Kenya did not seem to have a proportional effect on the incidence of cervical cancer. Yet, HIV‐positive women who presented with cervical cancer were significantly younger than HIV‐negative women. | en_US |
dc.language.iso | en | en_US |
dc.publisher | International Journal of Gynecology & Obstetrics | en_US |
dc.subject | HIV | en_US |
dc.subject | Cervical cancer | en_US |
dc.subject | Kenya | en_US |
dc.title | HIV and cervical cancer in Kenya | en_US |
dc.type | Article | en_US |